Your browser doesn't support javascript.
loading
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.
van Helden, E J; Elias, S G; Gerritse, S L; van Es, S C; Boon, E; Huisman, M C; van Grieken, N C T; Dekker, H; van Dongen, G A M S; Vugts, D J; Boellaard, R; van Herpen, C M L; de Vries, E G E; Oyen, W J G; Brouwers, A H; Verheul, H M W; Hoekstra, O S; Menke-van der Houven van Oordt, C W.
Affiliation
  • van Helden EJ; Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Gerritse SL; Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • van Es SC; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Boon E; Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Huisman MC; Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • van Grieken NCT; Pathology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • Dekker H; Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • van Dongen GAMS; Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • Vugts DJ; Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • Boellaard R; Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • van Herpen CML; Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • de Vries EGE; Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Oyen WJG; Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Brouwers AH; The Institute of Cancer Research and The Royal Marsden Hospital, London, UK.
  • Verheul HMW; Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Hoekstra OS; Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
  • Menke-van der Houven van Oordt CW; Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands.
Eur J Nucl Med Mol Imaging ; 47(4): 849-859, 2020 04.
Article in En | MEDLINE | ID: mdl-31705176
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Prognostic_studies Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Prognostic_studies Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Germany